Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Classical hematology 1

Conditions

Glioblastoma 5Rectal Neoplasms 4Head and Neck Neoplasms 4Esophageal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Stomach Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Neoplasms 3Glioma 3Colorectal Neoplasms 3Carcinoma, Hepatocellular 3Astrocytoma 3Sarcoma 2Pancreatic Neoplasms 2Osteosarcoma 2Lung Neoplasms 2Carcinoma, Squamous Cell 2Breast Neoplasms 2Brain Neoplasms 2Wilms Tumor 1Urinary Bladder Neoplasms 1Skin Neoplasms 1Sinonasal Squamous Cell Carcinoma 1Rhabdomyosarcoma 1Radiation Injuries 1Prostatic Neoplasms 1Prostate Adenocarcinoma 1Postoperative Complications 1Pelvic Neoplasms 1Pathologic Complete Response 1

Interventions

Surgical Procedures, Operative 1S-Adenosylmethionine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hepatic Veno-Occlusive Disease × Surgical Procedures, Operative × 90 days × Clear all
NCT06258525 2026-05-06

SAMe in Prevention of Oxaliplatin-associated Liver Injury

Cedars-Sinai Medical Center

Phase 2 Not yet recruiting
30 enrolled
Classical hematologyGastrointestinal

Hepatic Veno-Occlusive Disease, Colorectal Neoplasms, Chemical and Drug Induced Liver Injury

Data powered by HemOnc (CC BY 4.0) Colophon âš¡